-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on WAVE Life Sciences, Raises Price Target to $29

Benzinga·12/09/2025 18:05:56
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight and raises the price target from $16 to $29.